Bingo, my friend! CBIS is in this very unique position in the US cannabis-pharma market. And for the long long term, they are in position to be the Kings of Canna when federal/FDA approval is achieved some day. Let's not lose site of the grand scheme, though news like 19 and the conference will provide little successes a long the way.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.